Literature DB >> 24078427

Infectious Complications of Mechanical Circulatory Support (MCS) Devices.

Stanley I Martin1.   

Abstract

Left-ventricular assist devices and other forms of mechanical circulatory support are increasingly important in the routine therapy of patients with end-stage congestive heart failure. Technology may help to decrease the rate of infections associated with these devices, but with larger numbers of implants being utilized across the globe, infections overall are becoming more commonplace. Becoming familiar with appropriate techniques for prevention and with the ideal approach to diagnostic and therapeutic strategies is key to managing mechanical circulatory support infections in this unique, but growing, patient population.

Entities:  

Year:  2013        PMID: 24078427     DOI: 10.1007/s11908-013-0366-9

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  38 in total

1.  Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis.

Authors:  J S Li; D J Sexton; N Mick; R Nettles; V G Fowler; T Ryan; T Bashore; G R Corey
Journal:  Clin Infect Dis       Date:  2000-04-03       Impact factor: 9.079

Review 2.  Left ventricular assist device infections: three case reports and a review of the literature.

Authors:  Kumudhini Sivaratnam; Joan M Duggan
Journal:  ASAIO J       Date:  2002 Jan-Feb       Impact factor: 2.872

3.  Candidemia in patients with ventricular assist devices.

Authors:  Shmuel Shoham; Rebecca Shaffer; Leslie Sweet; Richard Cooke; Nancy Donegan; Steven Boyce
Journal:  Clin Infect Dis       Date:  2006-12-14       Impact factor: 9.079

4.  The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary.

Authors:  David Feldman; Salpy V Pamboukian; Jeffrey J Teuteberg; Emma Birks; Katherine Lietz; Stephanie A Moore; Jeffrey A Morgan; Francisco Arabia; Mary E Bauman; Hoger W Buchholz; Mario Deng; Marc L Dickstein; Aly El-Banayosy; Tonya Elliot; Daniel J Goldstein; Kathleen L Grady; Kylie Jones; Katarzyna Hryniewicz; Ranjit John; Annemarie Kaan; Shimon Kusne; Matthias Loebe; M Patricia Massicotte; Nader Moazami; Paul Mohacsi; Martha Mooney; Thomas Nelson; Francis Pagani; William Perry; Evgenij V Potapov; J Eduardo Rame; Stuart D Russell; Erik N Sorensen; Benjamin Sun; Martin Strueber; Abeel A Mangi; Michael G Petty; Joseph Rogers
Journal:  J Heart Lung Transplant       Date:  2013-02       Impact factor: 10.247

5.  Infection after implantation of pulsatile mechanical circulatory support devices.

Authors:  William L Holman; James K Kirklin; David C Naftel; Robert L Kormos; Patricia Desvign-Nickens; Margarita T Camacho; Deborah D Ascheim
Journal:  J Thorac Cardiovasc Surg       Date:  2010-04-03       Impact factor: 5.209

6.  Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants.

Authors:  James K Kirklin; David C Naftel; Robert L Kormos; Lynne W Stevenson; Francis D Pagani; Marissa A Miller; Karen L Ulisney; J Timothy Baldwin; James B Young
Journal:  J Heart Lung Transplant       Date:  2010-01       Impact factor: 10.247

7.  Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients.

Authors:  James K Kirklin; David C Naftel; Robert L Kormos; Lynne W Stevenson; Francis D Pagani; Marissa A Miller; J T Baldwin; J Timothy Baldwin; James B Young
Journal:  J Heart Lung Transplant       Date:  2013-02       Impact factor: 10.247

8.  The epidemiology of heart failure: the Framingham Study.

Authors:  K K Ho; J L Pinsky; W B Kannel; D Levy
Journal:  J Am Coll Cardiol       Date:  1993-10       Impact factor: 24.094

9.  LVAD bloodstream infections: therapeutic rationale for transplantation after LVAD infection.

Authors:  Robert S Poston; Shahid Husain; Damian Sorce; Ellieen Stanford; Shimon Kusne; Margaret Wagener; Bartley P Griffith; Robert L Kormos
Journal:  J Heart Lung Transplant       Date:  2003-08       Impact factor: 10.247

10.  Does total implantability reduce infection with the use of a left ventricular assist device? The LionHeart experience in Europe.

Authors:  Walter E Pae; John M Connell; Amos Adelowo; John P Boehmer; Reiner Korfer; Aly El-Banayosy; Roland Hetzer; Mario Vigano; Alain Pavie
Journal:  J Heart Lung Transplant       Date:  2007-03       Impact factor: 10.247

View more
  1 in total

1.  Single-Center Experience With Protocolized Treatment of Left Ventricular Assist Device Infections.

Authors:  Nelianne J Verkaik; Yunus C Yalcin; Hannelore I Bax; Alina A Constantinescu; Jasper J Brugts; Olivier C Manintveld; Ozcan Birim; Peter D Croughs; Ad J J C Bogers; Kadir Caliskan
Journal:  Front Med (Lausanne)       Date:  2022-05-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.